Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 4
2008 2
2009 2
2011 1
2012 1
2014 1
2019 1
2020 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary.
Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B, Wigal T; MTA Cooperative Group. Swanson J, et al. J Atten Disord. 2008 Jul;12(1):4-14. doi: 10.1177/1087054708319345. J Atten Disord. 2008. PMID: 18573923
Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details.
Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B, Wigal T; MTA Cooperative Group. Swanson J, et al. J Atten Disord. 2008 Jul;12(1):15-43. doi: 10.1177/1087054708319525. J Atten Disord. 2008. PMID: 18573924
Effects of stimulant medication on growth rates across 3 years in the MTA follow-up.
Swanson JM, Elliott GR, Greenhill LL, Wigal T, Arnold LE, Vitiello B, Hechtman L, Epstein JN, Pelham WE, Abikoff HB, Newcorn JH, Molina BSG, Hinshaw SP, Wells KC, Hoza B, Jensen PS, Gibbons RD, Hur K, Stehli A, Davies M, March JS, Conners CK, Caron M, Volkow ND. Swanson JM, et al. J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):1015-1027. doi: 10.1097/chi.0b013e3180686d7e. J Am Acad Child Adolesc Psychiatry. 2007. PMID: 17667480 Clinical Trial.
3-year follow-up of the NIMH MTA study.
Jensen PS, Arnold LE, Swanson JM, Vitiello B, Abikoff HB, Greenhill LL, Hechtman L, Hinshaw SP, Pelham WE, Wells KC, Conners CK, Elliott GR, Epstein JN, Hoza B, March JS, Molina BSG, Newcorn JH, Severe JB, Wigal T, Gibbons RD, Hur K. Jensen PS, et al. J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):989-1002. doi: 10.1097/CHI.0b013e3180686d48. J Am Acad Child Adolesc Psychiatry. 2007. PMID: 17667478 Clinical Trial.
Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment.
Pappadopulos E, Jensen PS, Chait AR, Arnold LE, Swanson JM, Greenhill LL, Hechtman L, Chuang S, Wells KC, Pelham W, Cooper T, Elliott G, Newcorn JH. Pappadopulos E, et al. J Am Acad Child Adolesc Psychiatry. 2009 May;48(5):501-510. doi: 10.1097/CHI.0b013e31819c23ed. J Am Acad Child Adolesc Psychiatry. 2009. PMID: 19307987 Clinical Trial.
The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study.
Molina BSG, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, Epstein JN, Hoza B, Hechtman L, Abikoff HB, Elliott GR, Greenhill LL, Newcorn JH, Wells KC, Wigal T, Gibbons RD, Hur K, Houck PR; MTA Cooperative Group. Molina BSG, et al. J Am Acad Child Adolesc Psychiatry. 2009 May;48(5):484-500. doi: 10.1097/CHI.0b013e31819c23d0. J Am Acad Child Adolesc Psychiatry. 2009. PMID: 19318991 Free PMC article. Clinical Trial.
Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects.
Molina BSG, Flory K, Hinshaw SP, Greiner AR, Arnold LE, Swanson JM, Hechtman L, Jensen PS, Vitiello B, Hoza B, Pelham WE, Elliott GR, Wells KC, Abikoff HB, Gibbons RD, Marcus S, Conners CK, Epstein JN, Greenhill LL, March JS, Newcorn JH, Severe JB, Wigal T. Molina BSG, et al. J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):1028-1040. doi: 10.1097/chi.0b013e3180686d96. J Am Acad Child Adolesc Psychiatry. 2007. PMID: 17667481 Clinical Trial.
Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses.
Swanson JM, Hinshaw SP, Arnold LE, Gibbons RD, Marcus S, Hur K, Jensen PS, Vitiello B, Abikoff HB, Greenhill LL, Hechtman L, Pelham WE, Wells KC, Conners CK, March JS, Elliott GR, Epstein JN, Hoagwood K, Hoza B, Molina BSG, Newcorn JH, Severe JB, Wigal T. Swanson JM, et al. J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):1003-1014. doi: 10.1097/CHI.0b013e3180686d63. J Am Acad Child Adolesc Psychiatry. 2007. PMID: 17667479
11 results